BamSEC and AlphaSense Join Forces
Learn More

Outlook Therapeutics Inc. – Underwriting Agreements

NASDAQ: OTLK    
Share price (9/22/26): $0.70    
Market cap (9/22/26): $169 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.1
from 8-K 42 pages Outlook Therapeutics, Inc. (A Delaware Corporation) 55,555,556 Shares of Common Stock Warrants to Purchase Up to 55,555,556 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from SCHEDULE 13D/A 1 page Joint Filing Agreement
12/34/56
EX-1.1
from 8-K 41 pages Outlook Therapeutics, Inc. (A Delaware Corporation) 9,285,714 Shares of Common Stock Warrants to Purchase Up to 18,571,428 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 43 pages Outlook Therapeutics, Inc. 40,000,000 Shares of Common Stock (Par Value $0.01 Per Share) Amended and Restated Underwriting Agreement
12/34/56
EX-1.1
from 8-K 43 pages Outlook Therapeutics, Inc. 35,000,000 Shares of Common Stock (Par Value $0.01 Per Share) Amended and Restated Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 36 pages Outlook Therapeutics, Inc. [●] Shares of Common Stock 15-Month Warrants to Purchase Up to [●] Shares of Common Stock Five-Year Warrants to Purchase Up to [●] Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 35 pages Outlook Therapeutics, Inc. [●] Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 40 pages Oncobiologics, Inc. [ ] Units 1 Each Unit Consisting of One Share of Common Stock ($0.01 Par Value), One Half of a Series a Warrant to Purchase One Share of Common Stock and One Half of a Series B Warrant to Purchase One Share of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 40 pages Oncobiologics, Inc. [ ] Shares1 Common Stock ($0.01 Par Value) Underwriting Agreement
12/34/56